We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $227M invested in Standard BioTools in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $189K | Put options by funds: $131K

2.34% more ownership

Funds ownership: 95.42% → 97.77% (+2.3%)

5% more capital invested

Capital invested by funds: $217M → $227M (+$10.3M)

0% more funds holding

Funds holding: 84 → 84 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

4% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 28

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
27
Reduced
28
Closed
15
Calls
$189K
Puts
$131K
Net Calls
+$58K
Net Calls Change
+$47K

Top Buyers

1
Russell Investments Group
Russell Investments Group
United Kingdom
+$3.9M
2
LCS
Levin Capital Strategies
New York
+$2.81M
3
SSA
Schonfeld Strategic Advisors
New York
+$858K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$711K
5
Renaissance Technologies
Renaissance Technologies
New York
+$674K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.21M
2
Goldman Sachs
Goldman Sachs
New York
-$813K
3
Northern Trust
Northern Trust
Illinois
-$602K
4
Millennium Management
Millennium Management
New York
-$540K
5
Morgan Stanley
Morgan Stanley
New York
-$498K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$13K – – –
CF
77
Centaurus Financial
California
$9K +$8.55K +1,500 New
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$4.75K -$46.9K -8,232 -91%
MFW
79
Mosaic Family Wealth
Missouri
$4K – – –
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K -$182K -31,912 -98%
Fifth Third Bancorp
81
Fifth Third Bancorp
Ohio
$3K – – –
PIA
82
Piedmont Investment Advisors
North Carolina
$3K +$2.6K +456 New
Bank of Montreal
83
Bank of Montreal
Ontario, Canada
$1K +$1.04K +182 New
EI
84
EAM Investors
California
– -$459K -78,554 Closed
Balyasny Asset Management
85
Balyasny Asset Management
Illinois
– -$149K -25,488 Closed
MIM
86
MetLife Investment Management
New Jersey
– -$120K -20,596 Closed
SAM
87
Silverback Asset Management
North Carolina
– -$116K -19,898 Closed
Adage Capital Partners
88
Adage Capital Partners
Massachusetts
– -$109K -18,726 Closed
SAM
89
Silphium Asset Management
United Kingdom
– -$92.6K -15,848 Closed
CS
90
Credit Suisse
Switzerland
– -$89K -15,316 Closed
MLICM
91
Metropolitan Life Insurance Company (MetLife)
New York
– -$81.6K -13,975 Closed
DTL
92
Dynamic Technology Lab
Singapore
– -$80K -13,618 Closed
SIM
93
Spark Investment Management
New York
– -$73K -12,500 Closed
Simplex Trading
94
Simplex Trading
Illinois
– -$53.5K -9,382 Closed
WAM
95
Wealthspire Advisors (Maryland)
Maryland
– -$6K -1,069 Closed
DZ Bank
96
DZ Bank
Germany
– -$208K -348 Closed
TDC
97
Thompson Davis & Co
Virginia
– -$1K -250 Closed
RCAG
98
Rehmann Capital Advisory Group
Michigan
– -$1K -153 Closed
Royal Bank of Canada
99
Royal Bank of Canada
Ontario, Canada
– +$34 +6 +50%
1 2 3
4

LAB Hedge Fund Activity: Q2 2018 in Review

84 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2018, worth a combined $227M — up 4.7% from $217M a quarter earlier.

Fund positioning in LAB was balanced in Q2 2018: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 28 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $3.9M. The largest seller was BlackRock, cutting an estimated $1.21M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $227M of Standard BioTools stock for Q2 2018, up 4.7% quarter-over-quarter.
  • 15 funds opened new Standard BioTools positions in Q2 2018 and 15 closed out, a net change of 0 holders.
  • The largest Standard BioTools buyer in Q2 2018 was Russell Investments Group, an estimated $3.9M added.
  • The largest Standard BioTools seller in Q2 2018 was BlackRock, an estimated $1.21M sold.

Based on aggregated 13F filings for Q2 2018.